In recent weeks, several biotech companies have released positive news around Q2 financials, and several are set to release updates this week. Making it a sector to watch.
With news coming fast and furious in the sector it is good to know some of the players in the industry.
One small cap biotech company that we have discovered BRTX (BioRestorative Therapies, Inc.). BRTX is on the cusp of receive major attention from the street. As BRTX prepares for it’s Phase 2 clinical trial using BRTX-100 to treat chronic lumbar disc disease, the company is flying under the radar of most investors, which presents a great opportunity to investors that are currently in the know on BRTX. And the company just had very important, as well as favorable news which could lead to even more developments for the company. Keep BRTX on your radar because missing out on this very innovative and interest company would be very disappointing
A few biotech companies with important news include: BioRestorative Therapies, Inc. (BRTX), Geron Corporation (GERN)
BioRestorative Therapies, Inc. (BRTX)
Market Cap: $10.57M Share Price: $1.59
BioRestorative Therapies, Inc. (BRTX), a life sciences company focused on stem cell-based therapies, recently announced the appointment of Jason S. Lipetz, M.D. to the Company’s Scientific Advisory Board. Dr. Lipetz has an impressive resume and will certainly add clinical expertise as the Company prepares for its Phase 2 trial using BRTX-100 to treat chronic lumbar disc disease. So far the stock has been trading sideways, announcements like these many times lead to more news in the near future. Investors should monitor this situation closely.
Geron Corporation (GERN)
Market Cap: $578.09M Share Price: $3.34
Favorable second quarter earnings helped CELG, GERN investors are hoping for a similar outcome after Geron Corporation (GERN) reports its second quarter 2018 financial results after the market closes on Tuesday, July 31, 2018.
Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. ACR Communication, LLC, which owns Microcapspeculators.com, is not registered with Finra or any other financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. ACR Communication, LLC [and/or] Microcapspeculators.com does not have a position in the securities mentioned herein and may increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice. ACR Communication LLC, which owns Microcapspeculators.com, is compensated for its services in the form of cash-based compensation or in equity in the companies it writes about, or a combination of the two. ACR Communication, LLC has been compensated one thousand dollars cash for this article and six thousand dollars total by Regal Consulting. LLC, for news commentary articles for BRTX. BRTX and Regal Consulting, LLC were given an opportunity to edit information included in this article. This article is based solely on public information and the opinions of ACR Communication, LLC, which believes the news commentary to include accurate and complete information. ACR Communication, LLC, will not buy or sell any shares in stocks contained within this article for forty eight hours after this article’s distribution.
For Full Legal Disclaimer Click Here.
Company Name: Microcap Speculators
Contact Person: Media Manager
Country: United States